Stopping Wegovy: what actually happens and how to think about it

Why your body responds the way it does when semaglutide stops

Semaglutide works by activating GLP-1 receptors that help regulate appetite, slow the rate at which food leaves your stomach, and signal fullness to your brain. While the medicine is active, many people notice that food feels less urgent, portion sizes fall naturally, and snacking between meals stops without effort. That shift is pharmacological, not a rewiring of your appetite for good.

The half-life of semaglutide is roughly a week, so it clears slowly compared with a daily tablet, but within two to four weeks of your last injection, most of the clinical effect has gone. The NHS medicines page for semaglutide describes this mechanism clearly. Hunger, cravings, and your previous relationship with food can return as the medicine washes out. For some people the shift is gradual; for others it feels quite sudden, especially if appetite had been well-controlled at a higher dose.

None of this means the treatment failed. It means obesity is a chronic condition that responds to treatment while the treatment is present, much like blood pressure responds to antihypertensives. The Wegovy treatment overview explains this framing in more detail, and it is worth reading before making any decision about your next step.

What the evidence says about weight regain after stopping

This is the part most people find difficult to hear, but honest information matters more than reassurance here. In the STEP 1 extension study, participants who stopped semaglutide 2.4mg after 68 weeks regained, on average, about two-thirds of the weight they had lost within the following year, reverting toward their starting weight even while continuing lifestyle support. The STEP 1 trial, published in the New England Journal of Medicine, is the foundational evidence for Wegovy's effectiveness, and the extension data sit alongside it.

That statistic is not a counsel of despair; it is useful information. It tells you that whatever lifestyle habits you have built during treatment (eating patterns, activity, sleep) need to be solid enough to carry more of the load once the medicine is gone. People who have used the lower-appetite phase to genuinely restructure their eating tend to regain less. People who relied almost entirely on appetite suppression without changing underlying habits tend to regain more.

Weight regain is also not linear or inevitable for everyone. Some people maintain a meaningful proportion of their loss. The point is that planning matters: discussing with your prescriber before stopping (rather than simply running out and not reordering) gives you the best chance of protecting what you have achieved. If you want to understand what typical results look like on Wegovy, our page on typical weight loss on Wegovy covers the trial data in detail.

The decision itself: planned pause, permanent stop, or transition

Not every reason for stopping is the same, and they call for different approaches. A planned pause (for surgery, pregnancy planning, or a period when you need to step back) is different from simply running out of medication mid-month. It is also different from completing a course having reached your goal weight and built sustainable habits. And it is different again from stopping because side effects have become intolerable.

If you are pausing for a defined reason and intend to restart, keeping your prescriber informed means they can review your progress when you return rather than treating you as a new patient. Some people time their pause to coincide with a quieter period (after a holiday, for example, or when other life pressures ease) so that the appetite changes arrive when they have the headspace to manage them. If you are stopping because side effects feel difficult, there is almost always a clinical conversation worth having first: for many people, a slower titration or a return to a lower dose resolves the problem. Our guide to what to expect when you start Wegovy covers side effects across the treatment course in detail.

For people considering a transition rather than a stop (perhaps moving to a different treatment or exploring whether tirzepatide might suit them better) that conversation belongs with a prescriber too. The clinical picture that made you suitable for one medicine shapes whether another would be appropriate. You can read more about your options on our weight loss treatment overview.

Protecting your progress after the last dose

There is no single protocol for stopping Wegovy, and the NHS England guidance on weight management injections emphasises that behavioural and dietary support remains important whether or not treatment continues. Practically, that means the period immediately after stopping is not the moment to relax the habits you built during treatment, it is exactly the moment to lean on them.

Protein adequacy, regular meals, staying well hydrated, and maintaining whatever physical activity you have built are the evidence-backed levers you still control. Many people also find it helpful to weigh themselves regularly in the weeks after stopping, and if you are curious about what to expect in week 1 of Wegovy, including how quickly appetite and hunger signals can shift after stopping, that page is a useful reference. Catching two or three kilograms of regain early is much easier to address than discovering eight or ten months later.

If you reach a point where appetite has fully returned and you are regaining weight at a rate that concerns you, that is a clinical question worth raising rather than managing alone. The right answer might be restarting treatment, and our page on what to expect at week 5 of Wegovy can help you recall how appetite control typically develops as the dose builds, which is useful context when weighing up whether to restart. Our prescribers review every consultation individually, if you would like to talk through your options, start your free consultation and a GPhC-registered prescriber will read your answers the same day.